"FDA Approves Colchicine (Lodoco) as a Groundbreaking Anti-inflammatory Medication for Preventing Cardiovascular Diseases"

The U.S. Food and Drug Administration (FDA) has approved the use of colchicine (Lodoco) for the prevention of cardiovascular diseases on behalf of AGEPHA Pharma.

It is the first anti-inflammatory medication that reduces the risk of heart attacks by 31% and is taken orally once daily.